Black Diamond Therapeutics Inc. (NASDAQ: BDTX)
$2.2300
+0.0100 ( -0.45% ) 0.1K
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
Market Data
Open
$2.2300
Previous close
$2.2200
Volume
0.1K
Market cap
$125.62M
Day range
$2.2400 - $2.3750
52 week range
$2.0900 - $7.6600
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 2 | Apr 12, 2024 |
3 | Insider transactions | 2 | Apr 12, 2024 |
8-k | 8K-related | 15 | Apr 11, 2024 |
4 | Insider transactions | 1 | Apr 03, 2024 |
4 | Insider transactions | 2 | Apr 03, 2024 |
10-k | Annual reports | 86 | Mar 12, 2024 |
8-k | 8K-related | 16 | Mar 12, 2024 |
4 | Insider transactions | 1 | Feb 15, 2024 |
4 | Insider transactions | 1 | Feb 15, 2024 |
4 | Insider transactions | 1 | Feb 15, 2024 |